| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |